Neurones Toekomstige groei

Future criteriumcontroles 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Neurones.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

IT winstgroei	13.8%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	28 Oct 2024

Recente toekomstige groei-updates

Recent updates

Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 09

The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

Feb 16

Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

Jan 25

What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Jan 11

Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

Dec 28

Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

Dec 15

What We Learned About Neurones' (EPA:NRO) CEO Pay

Dec 02

Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Nov 17

Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Jun 30

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Neurones onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

ENXTPA:NRO - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2024	800	50	N/A	N/A	1
6/30/2024	775	48	43	62	N/A
3/31/2024	758	49	49	67	N/A
12/31/2023	741	49	54	72	N/A
9/30/2023	724	49	59	74	N/A
6/30/2023	707	48	64	76	N/A
3/31/2023	686	46	54	65	N/A
12/31/2022	665	44	44	55	N/A
9/30/2022	642	43	42	51	N/A
6/30/2022	618	41	40	47	N/A
3/31/2022	599	40	49	56	N/A
12/31/2021	580	38	58	64	N/A
9/30/2021	570	37	58	65	N/A
6/30/2021	559	36	58	66	N/A
3/31/2021	542	33	59	67	N/A
12/31/2020	524	31	60	67	N/A
9/30/2020	518	30	61	69	N/A
6/30/2020	511	28	63	70	N/A
3/31/2020	510	30	58	66	N/A
12/31/2019	510	31	53	61	N/A
9/30/2019	505	30	46	53	N/A
6/30/2019	501	30	38	45	N/A
3/31/2019	495	28	31	38	N/A
12/31/2018	490	26	24	31	N/A
9/30/2018	487	26	20	28	N/A
6/30/2018	483	26	16	25	N/A
3/31/2018	484	27	N/A	24	N/A
12/31/2017	485	27	N/A	23	N/A
9/30/2017	478	27	N/A	24	N/A
6/30/2017	470	27	N/A	25	N/A
3/31/2017	459	26	N/A	23	N/A
12/31/2016	447	25	N/A	21	N/A
9/30/2016	436	24	N/A	21	N/A
6/30/2016	425	23	N/A	20	N/A
3/31/2016	412	22	N/A	25	N/A
12/31/2015	399	21	N/A	30	N/A
9/30/2015	386	21	N/A	30	N/A
6/30/2015	374	21	N/A	29	N/A
3/31/2015	364	21	N/A	29	N/A
12/31/2014	355	21	N/A	29	N/A
9/30/2014	354	20	N/A	26	N/A
6/30/2014	352	20	N/A	24	N/A
3/31/2014	347	19	N/A	22	N/A
12/31/2013	343	19	N/A	20	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if NRO's forecast earnings growth is above the savings rate (1.2%).

Winst versus markt: Insufficient data to determine if NRO's earnings are forecast to grow faster than the French market

Hoge groeiwinsten: Insufficient data to determine if NRO's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: Insufficient data to determine if NRO's revenue is forecast to grow faster than the French market.

Hoge groei-inkomsten: Insufficient data to determine if NRO's revenue is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if NRO's Return on Equity is forecast to be high in 3 years time

Neurones Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Neurones S.A. Provides Earnings Guidance for the Year 2024

Neurones S.A. Provides Earnings Guidance for the Year 2023

Neurones S.A. Provides Earnings Guidance for the Full Year 2023

Neurones S.A. Provides Earnings Guidance for the Full Year 2023

Price target increased to €44.33

Neurones S.A. Confirms its Earnings Guidance for the Full Year 2022

Recent updates

Neurones S.A. to Report First Half, 2025 Results on Sep 10, 2025

Now 21% undervalued after recent price drop

What Neurones S.A.'s (EPA:NRO) P/E Is Not Telling You

Upcoming dividend of €1.20 per share

Neurones S.A. Provides Earnings Guidance for the Year 2024

Dividend of €1.20 announced

Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes

Now 20% overvalued after recent price rise

Full year 2023 earnings released

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Neurones S.A. to Report Fiscal Year 2023 Results on Mar 06, 2024

Neurones S.A. Provides Earnings Guidance for the Year 2023

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

First half 2023 earnings released

Neurones S.A. Provides Earnings Guidance for the Full Year 2023

Upcoming dividend of €1.10 per share at 2.8% yield

If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity

Neurones S.A. Provides Earnings Guidance for the Full Year 2023

Full year 2022 earnings released

Neurones' (EPA:NRO) Returns Have Hit A Wall

Neurones S.A. to Report Fiscal Year 2022 Results on Mar 08, 2023

Price target increased to €44.33

Less than half of directors are independent

Neurones S.A., Annual General Meeting, Jun 08, 2023

Neurones S.A. to Report First Half, 2023 Results on Sep 06, 2023

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?

Neurones S.A. Confirms its Earnings Guidance for the Full Year 2022

First half 2022 earnings released

Neurones S.A. Provides Earnings Guidance for the Year 2022

Upcoming dividend of €1.00 per share

Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year

Full year 2021 earnings: Revenues in line with analyst expectations

Price target increased to €41.00

Less than half of directors are independent

Full year 2021 earnings: Revenues in line with analyst expectations

Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?

Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture

Upcoming dividend of €2.00 per share

Price target increased to €32.50

Price target increased to €31.00

Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?

Full year 2020 earnings released: EPS €1.28 (vs €1.27 in FY 2019)

Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital

Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Full year 2020 earnings released

Revenue beats expectations

The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

New 90-day high: €25.70

Price target raised to €29.00

Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

Price target raised to €28.25

What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

New 90-day low: €23.00

Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

What We Learned About Neurones' (EPA:NRO) CEO Pay

Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Analysts increase EPS estimates to €1.12

Neurones S.A. to Report Fiscal Year 2020 Results on Mar 03, 2021

First half earnings released

New 90-day high - €25.60

Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen